Warning
Ascend Laboratories Recalls Ascend Laboratories
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0547-2026Drug / Pharmaceutical
Ascend Laboratories Recalls Ascend Laboratories
Ascend Laboratories, LLC · Class II — Moderate Risk
Product Description
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Reason for Recall
Failed Dissolution Specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Ascend Laboratories, LLC has recalled a pharmaceutical product that the FDA classified as Class II affecting 17,304 100-count bottles. The recall was initiated on April 27, 2026. Failed Dissolution Specifications. It was distributed in U.S. Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.